AI-assisted, human-published
11/20/2024 /Funding Events
Forte Biosciences Secures $53M Equity Financing to Advance FB102 Therapy for Autoimmune Diseases
Forte Biosciences closes oversubscribed $53 million equity financing round to progress FB102 therapy for autoimmune diseases and prepares for upcoming R&D Day.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com